Maintenance ChemotherapyAntineoplastic Combined Chemotherapy Protocols6-MercaptopurinePrecursor Cell Lymphoblastic Leukemia-LymphomaCyclophosphamideMethotrexateThioguanineCombined Modality TherapyVincristineDisease-Free SurvivalDrug Administration ScheduleChemotherapy, AdjuvantRemission InductionTreatment OutcomeCytarabineEtoposideDaunorubicinLung NeoplasmsPrednisoneLeukemia, LymphoidCarcinoma, Small CellSurvival AnalysisClinical Trials as TopicTime FactorsFollow-Up StudiesRecurrenceAntineoplastic AgentsCisplatinDoxorubicinNeoadjuvant TherapyBreast NeoplasmsNeoplasm StagingSurvival RatePrognosisCarboplatinPaclitaxelInduction ChemotherapyVinblastineNeoplasmsNeoplasm Recurrence, LocalTaxoidsIfosfamideDrug Resistance, NeoplasmAntimetabolites, AntineoplasticDeoxycytidineBleomycinOrganoplatinum CompoundsAntineoplastic Agents, AlkylatingCarcinoma, Non-Small-Cell LungSalvage TherapyAnthracyclinesNeoplasm MetastasisVomitingProspective StudiesNeutropeniaChemotherapy, Cancer, Regional PerfusionOvarian NeoplasmsNauseaInfusions, IntravenousRadiotherapy DosageAntineoplastic Agents, PhytogenicAdenocarcinomaTransplantation, AutologousMaintenanceLymphoma, Non-HodgkinRadiotherapyTesticular NeoplasmsAdministration, OralRadiotherapy, AdjuvantHodgkin DiseaseAntibiotics, AntineoplasticColorectal NeoplasmsDacarbazineBrain NeoplasmsKaplan-Meier EstimateGranulocyte Colony-Stimulating FactorCamptothecinCarmustineCell Line, TumorDose-Response Relationship, DrugLeukopeniaMelphalanNeoplasms, Germ Cell and EmbryonalLomustineBone NeoplasmsMitomycinInfusions, Intra-ArterialHematopoietic Stem Cell TransplantationAntibodies, Monoclonal, HumanizedLiver NeoplasmsOsteosarcomaAntibodies, MonoclonalAntiemeticsPlatinum CompoundsMitoxantroneRandomized Controlled Trials as TopicTumor Markers, BiologicalDrug TherapyPeritoneal NeoplasmsDisease Progression